Have a personal or library account? Click to login
The Top 100 Cited Articles in Essential Tremor Cover

The Top 100 Cited Articles in Essential Tremor

Open Access
|Sep 2013

Full Article

Introduction

The number of times an article is cited in scientific journals reflects its impact on a specific biomedical field or specialty and reflects the impact of the authors’ creativity.13 The Institute for Scientific Information (ISI) has been collecting citation and other academic impact information since 1945, and this information has been electronically available since 1979. ISI (now a subsidiary of Thomson Corp.) has named their newest journal citation system “Science Citation Index Expanded,” and it is one of the databases available under the banner of the Web of Science.4 Citation data from peer-reviewed articles are indexed for more than 10,000 high-impact journals in the sciences and social sciences, as well as in the arts and humanities.

In recent years, several citation analyses of the top-cited articles have become available for various areas of clinical neurology and neurosurgery, including epilepsy,5 multiple sclerosis,6 Parkinson’s disease,7 brain metastases research,8 and neurosurgery.911 However, no similar study has been performed in the field of essential tremor (ET). ET is one of the most common involuntary movement disorders, and it is the most common tremor disorder.1214 The past few years have witnessed an exponential growth in the number of scientific publications on ET, mainly across the disciplines of epidemiology, clinical features, and pathology.1518

We used the electronic version of the Science Citation Index Expanded to determine which published articles in ET have been cited most often by ranking the 100 top-cited works. The expectation was to provide references for future studies and clinical practices.

Methods

A search was performed using the bibliometric database ISI Web of Science for articles including the keyword “Essential tremor*” in the title (the asterisk was included in the search string as a wild card character). In early April 2013, we identified the 100 top-cited articles (Table 1) published in professional journals since 1960 by the Web of Science. All articles in each given journal were ranked by the number of citations listed on Web of Science. The full texts were mainly selected by PubMed and ScienceDirect.

TABLE 1

The 100 Top-Cited ET Articles

RankArticleNumber of Citations
1Benamer HTS, Patterson J, Grosset DG, et al. Accurate differentiation of parkinsonism and essential tremor using visual assessment of [123I]-FP-CIT SPECT imaging: the [123I]-FP-CIT study group. Mov Disord 2000;15:503–510.293
2Limousin P, Speelman JD, Gielen F, Janssens M. Multicentre European study of thalamic stimulation in parkinsonian and essential tremor. J Neurol Neurosurg Psychiatry 1999;66:289–296.264
3Louis ED, Ottman R, Allen Hauser W. How common is the most common adult movement disorder? Estimates of the prevalence of essential tremor throughout the world. Mov Disord 1998;13:5–10.203
4Bain PG, Findley LJ, Thompson PD, et al. A study of hereditary essential tremor. Brain 1994;117:805–824.202
5Lou JS, Jankovic J. Essential tremor: clinical correlates in 350 patients. Neurology 1991;41:234–238.164
6Gulcher JR, Jónsson P, Kong A, et al. Mapping of a familial essential tremor gene, FET1, to chromosome 3q13. Nat Gen 1997;17:84–87.154
7Jenkins IH, Bain PG, Colebatch JG, et al. A positron emission tomography study of essential tremor: evidence for overactivity of cerebellar connections. Ann Neurol 1993;34:82–90.153
8Benabid AL, Pollak P, Seigneuret E, Hoffmann D, Gay E, Perret J. Chronic VIM thalamic stimulation in Parkinson‘s disease, essential tremor and extra-pyramidal dyskinesias. Acta Neurochir Suppl (Wien) 1993;58:39–44.136
9Ondo W, Jankovic J, Schwartz K, Almaguer M, Simpson RK. Unilateral thalamic deep brain stimulation for refractory essential tremor and Parkinson’s disease tremor. Neurology 1998;51:1063–1069.133
10Louis ED. Essential tremor. Lancet Neurol 2005;4:100–110.132
11Louis ED, Faust PL, Vonsattel JP, et al. Neuropathological changes in essential tremor: 33 Cases compared with 21 controls. Brain 2007;130:3297–3307.131
12Rajput AH, Offord, KP, Beard CM, Kurland LT. Essential tremor in Rochester, Minnesota: a 45-year study. J Neurol Neurosurg Psychiatry 1984;47:466–470.130
13Koller WC, Busenbark K, Miner K, et al. The relationship of essential tremor to other movement disorders: report on 678 patients. Ann Neurol 1994;35:717–723.128
14Deuschl G, Wenzelburger R, Löffler K, Raethjen J, Stolze H. Essential tremor and cerebellar dysfunction. Clinical and kinematic analysis of intention tremor. Brain 2000;123:1568–1580.127
15Higgins JJ, Pho LT, Nee LE. A gene (ETM) for essential tremor maps to chromosome 2p22–p25. Mov Disord 1997;12:859–864.126
16Benito-León J, Bermejo-Pareja F, Morales J-M, Vega S, Molina J-A. Prevalence of essential tremor in three elderly populations of central Spain. Mov Disord 2003;18:389–394.118
17Dogu, O, Sevim S, Camdeviren H, et al. Prevalence of essential tremor: door-to-door neurologic exams in Mersin Province, Turkey. Neurology 2003;61:1804–1806112
18Stolze, H, Petersen, G, Raethjen J, Wenzelburger R, Deuschl G. The gait disorder of advanced essential tremor. Brain 2002;124:2278–2286.110
19Gironell A, Kulisevsky J, Barbanoj M, López-Villegas D, Hernández G, Pascual-Sedano B. A randomized placebo-controlled comparative trial of gabapentin and propranolol in essential tremor. Arch Neurol 1999;56:475–480.110
20Elble, RJ. Physiologic and essential tremor. Neurology 1986;36:225–231.109
21Zesiewicz TA, Elble RJ, Louis ED, et al. Practice parameter: therapies for essential tremor: report of the quality standards subcommittee of the American Academy of Neurology. Neurology 2005;64:2008–2020.105
22Asenbaum S, Pirker W, Angelberger P, Bencsits G, Pruckmayer M, Brücke T. [123I]β-CIT and SPECT in essential tremor and Parkinson’s disease. J Neural Transm 1998;105:1213–1228.100
23Bucher SF, Seelos KC, Dodel RC, Reiser M, Oertel WH. Activation mapping in essential tremor with functional magnetic resonance imaging. Ann Neurol 1997;41:32–40.100
24Wills AJ, Jenkins IH, Thompson PD, Findley LJ, Brooks DJ. Red nuclear and cerebellar but no olivary activation associated with essential tremor: a positron emission tomographic study. Ann Neurol 1994;36:636–642.100
25Alesch F, Pinter MM, Helscher RJ, Fertl L, Benabid AL, Koos WT. Stimulation of the ventral intermediate thalamic nucleus in tremor dominated Parkinson’s disease and essential tremor. Acta Neurochir (Wien) 1995;136:75–81.99
26Deuschl G, Elble RJ. The pathophysiology of essential tremor. Neurology 2000;54(11 SUPPL. 4):S14–S20.98
27Cohen O, Pullman S, Jurewicz E, Watner D, Louis ED. Rest tremor in patients with essential tremor: prevalence, clinical correlates, and electrophysiologic characteristics. Arch Neurol 2003;60:405–410.97
28Bain P, Brin M, Deuschl G, et al. Criteria for the diagnosis of essential tremor. Neurology 2000;54(11 SUPPL. 4):S797
29Laesson T, Sjogren T. Essential tremor: a clinical and genetic population study. Acta Psychiatr Scand Suppl 1960;36:1–176.96
30Louis ED, Marder K, Cote L, et al. Differences in the prevalence of essential tremor among elderly African Americans, whites, and Hispanics in Northern Manhattan, NY. Arch Neurol 1995;52:1201–1205.95
31Koller WC, Lyons KE, Wilkinson SB, Troster AI, Pahwa R. Long-term safety and efficacy of unilateral deep brain stimulation of the thalamus in essential tremor. Mov Disord 2001;16:464–468.94
32Elble RJ. Diagnostic criteria for essential tremor and differential diagnosis. Neurology 2000;54(11 SUPPL. 4):S2–S6.94
33Rautakorpi I, Takala J, Marttila RJ, Sievers K, Rinne UK. Essential tremor in a Finnish population. Acta Neurologica Scand 1982;66:58–67.91
34Louis ED, Ottman R, Ford B, et al. The Washington Heights-Inwood Genetic Study of Essential tremor: methodologic issues in Essential-tremor research. Neuroepidemiology 1997;16:124–133.88
35Colebatch JG, Findley LJ, Frackowiak RSJ, Marsden CD, Brooks DJ. Preliminary report: activation of the cerebellum in essential tremor. Lancet 1990;336:1028–1030.88
36Hariz MI, Shamsgovara P, Johansson F, Hariz G-M, Fodstad H. Tolerance and tremor rebound following long-term chronic thalamic stimulation for Parkinsonian and essential tremor. Stereotact Funct Neurosurg 1999;72:208–218.86
37Singer C, Sanchez-Ramos J, Weiner WJ. Gait abnormality in essential tremor. Mov Disord 1994;9:193–196.86
38Benito-León J, Louis ED. Essential tremor: emerging views of a common disorder. Nat Clin Pract Neurol 2006;2:666–678.85
39Louis ED, Zheng W, Jurewicz EC, et al. Elevation of blood Β-carboline alkaloids in essential tremor. Neurology 2002;59:1940–1944.85
40Louis ED, Ottman R. How familial is familial tremor? The genetic epidemiology of essential tremor. Neurology 1996;46:1200–120585
41Lombardi WJ, Woolston DJ, Roberts JW, Gross RE. Cognitive deficits in patients with essential tremor. Neurology 2001;57:785–790.84
42Louis ED, Shungu DC, Chan S, Mao X, Jurewicz EC, Watner D. Metabolic abnormality in the cerebellum in patients with essential tremor: a proton magnetic resonance spectroscopic imaging study. Neurosci Lett 2002;333:17–20.83
43Louis ED, Barnes L, Albert SM, et al. Correlates of functional disability in essential tremor. Mov Disord 2001;16:914–920.83
44Leehey MA, Munhoz RP, Lang AE, et al. The fragile X premutation presenting as essential tremor. Arch Neurol 2003;60:117–121.82
45Boecker H, Wills AJ, Ceballos-Baumann A, et al. The effect of ethanol on alcohol-responsive essential tremor: a position emission tomography study. Ann Neurol 1996;39:650–658.81
46Benito-León J, Louis ED, Bermejo-Pareja F. Population-based case-control study of cognitive function in essential tremor Neurology 2006;66:69–74.80
47Pahwa R, Lyons K, Hubble JP, et al. Double-blind controlled trial of gabapentin in essential tremor. Mov Disord 1998;13:465–467.80
48Raethjen J, Lindemann M, Schmaljohann H, Wenzelburger R, Pfister G, Deuschl G. Multiple oscillators are causing parkinsonian and essential tremor. Mov Disord 2000;15:84–94.79
49Busenbark KL, Nash J, Nash S, Hubble JP, Koller WC. Is essential tremor benign? Neurology 1991;41:1982–1983.79
50Jankovic J. Essential tremor: a heterogeneous disorder. Mov Disord 2002;17:638–644.78
51Rajput, A, Robinson CA, Rajput AH. Essential tremor course and disability: a clinicopathologic study of 20 cases. Neurology 2004;62:932–936.77
52Louis ED, Ford B, Frucht S, Barnes LF, X-Tang M, Ottman R. Risk of tremor and impairment from tremor in relatives of patients with essential tremor: a community-based family study. Ann Neurol 2001;49:761–769.77
53Hellwig B, Häussler S, Schelter B, et al. Tremor-correlated cortical activity in essential tremor. Lancet 2001;357:519–523.77
54Hallett M, Dubinsky RM. Glucose metabolism in the brain of patients with essential tremor. J Neurol Sci 1993;114:45–48.76
55Benito-León J, Bermejo-Pareja, F, Louis ED. Incidence of essential tremor in three elderly populations of Central Spain. Neurology 2005;64:1721–1725.75
56Connor GS. A double-blind placebo-controlled trial of topiramate treatment for essential tremor. Neurology 2002;59:132–134.75
57Hubble JP, Busenbark KL, Wilkinson S, Penn RD, Lyons K, Koller WC. Deep brain stimulation for essential tremor. Neurology 1996;46:1150–1153.75
58Sydow O, Thobois S, Alesch F, Speelman JD. Multicentre European study of thalamic stimulation in essential tremor: a six year follow up. J Neurol Neurosurg Psychiatry 2003;74:1387–1391.74
59Helmchen C, Hagenow A, Miesner J, et al. Eye movement abnormalities in essential tremor may indicate cerebellar dysfunction. Brain 2003;126:1319–1332.74
60Ondo W, Hunter C, Vuong KD, Schwartz K, Jankovic J. Gabapentin for essential tremor: a multiple-dose, double-blind, placebo-controlled trial. Mov Disord 2000;15:678–682.73
61Jankovic, J. Essential tremor: clinical characteristics. Neurology 2000;54(11 SUPPL. 4):S21–S25.73
62Dupuis MJM, Delwaide PJ, Boucquey D, Gonsette RE. Homolateral disappearance of essential tremor after cerebellar stroke. Mov Disord 1989;4:183–187.73
63Louis ED, Ford B, Lee H, Andrews H. Does a screening questionnaire for essential tremor agree with the physician‘s examination? Neurology 1998;50:1351–1357.72
64Salemi G, Savettieri G, Rocca WA, et al. Prevalence of essential tremor: a door-to-door survey in Terrasini, Sicily. Neurology 1994;44:61–64.72
65Shahed J, Jankovic J. Exploring the relationship between essential tremor and Parkinson’s disease. Parkinsonism Relat Disord 2007;13:67–76.71
66Louis ED, Vonsattel JPG, Honig LS, Ross GW, Lyons KE, Pahwa R. Neuropathologic findings in essential tremor. Neurology 206;66:1756–1759.71
67Deng H, Le W, Jankovic J. Genetics of essential tremor. Brain 2007;130:1456–1464.70
68Higgins JJ, Loveless JM, Jankovic J, Patel PI. Evidence that a gene for essential tremor maps to chromosome 2p in four families. Mov Disord 1998;13:972–977.70
69Benito-León J, Louis ED, Bermejo-Pareja F. Elderly-onset essential tremor is associated with dementia. Neurology 2006;66:1500–1505.69
70Jeanneteau F, Funalot B, Jankovic J, et al. A functional variant of the dopamine D3 receptor is associated with risk and age-at-onset of essential tremor. Proc Natl Acad Sci U S A 2006;103:10753–10758.68
71Hubble JP, Busenbark KL, Pahwa R, Lyons K, Koller WC. Clinical expression of essential tremor: effects of gender and age. Mov Disord 1997;12:969–972.68
72Rajput AH, Rozdilsky B, Ang L, Rajput A. Clinicopathologic observations in essential tremor: report of six cases. Neurology 1991;41:1422–1424.68
73Louis ED. Essential tremor. N Engl J Med 2001;345:887–891.67
74Koller WC, Vetere-Overfield B. Acute and chronic effects of propranolol and primidone in essential tremor. Neurology 1989;39:1587–1588.67
75Geraghty JJ, Jankovic J, Zetusky WJ. Association between essential tremor and Parkinson’s disease. Ann Neurol 1985;17:329–333.67
76Hornabrook RW, Nagurney JT. Essential tremor in Papua New Guinea. Brain 1976;99:659–672.67
77Pahwa R, Lyons KL, Wilkinson SB, et al. Bilateral thalamic stimulation for the treatment of essential tremor. Neurology 1999;53:1447–1450.66
78Louis ED, Ford B, Lee H, Andrews H, Cameron G. Diagnostic criteria for essential tremor: a population perspective. Arch Neurol 1998;55:823–828.66
79Kralic JE, Criswell HE, Osterman JL, et al. Genetic essential tremor in γ-aminobutyric acidA receptor α1 subunit knockout mice. J Clin Invest 2005;115:774–779.65
80Tanner CM, Goldman SM, Lyons KE, et al. Essential tremor in twins: an assessment of genetic vs environmental determinants of etiology. Neurology 2001;57:1389–1391.65
81Findley LJ, Koller WC. Essential tremor: a review. Neurology 1987;37:1194–1197.65
82Bermejo-Pareja F, Louis ED, Benito-León J. Risk of incident dementia in essential tremor: a population-based study. Mov Disord 2007;22:1573–1580.64
83Tröster AI, Woods SP, Fields JA, et al. Neuropsychological deficits in essential tremor: an expression of cerebello-thalamo-cortical pathophysiology? Eur J Neurol 2002;9:143–151.64
84Pahwa R, Lyons KE, Wilkinson SB, et al. Comparison of thalamotomy to deep brain stimulation of the thalamus in essential tremor. Mov Disord 2001;16:140–143.64
85Hua SE, Lenz FA, Zirh TA, Reich SG, Dougherty PM. Thalamic neuronal activity correlated with essential tremor. J Neurol Neurosurg Psychiatry 1998;64:273–276.64
86Louis ED, Honig LS, Vonsattel JPG, Maraganore DM, Borden S, Moskowitz CB. Essential tremor associated with focal nonnigral Lewy bodies: a clinicopathologic study. Arch Neurol 2005;62:1004–1007.63
87Koller WC, Royse VL. Efficacy of primidone in essential tremor. Neurology 1986;36:121–124.62
88Louis ED, Ferreira JJ. How common is the most common adult movement disorder? Update on the worldwide prevalence of essential tremor. Mov Disord 2010;25:534–541.61
89Louis ED, Vonsattel JPG. The emerging neuropathology of essential tremor. Mov Disord 2008;23:174–182.61
90Findley LJ, Cleeves L, Calzetti S. Primidone in essential tremor of the hands and head: a double blind controlled clinical study. J Neurol Neurosurg Psychiatry 1985;48:911–915.61
91Axelrad JE, Louis ED, Honig LS, et al. Reduced Purkinje cell number in essential tremor: a postmortem study. Arch Neurol 2008;65:101–107.59
92Ondo WG, Jankovic J, Connor GS, et al. Topiramate in essential tremor: a double-blind, placebo-controlled trialNeurology 2006;66:672–677.59
93Gasparini M, Bonifati V, Fabrizio E, et al. Frontal lobe dysfunction in essential tremor: a preliminary study. J Neurol 2001;248:399–402.59
94Benito-León J, Louis ED, Bermejo-Pareja F. Risk of incident Parkinson’s disease and parkinsonism in essential tremor: a population based study. J Neurol Neurosurg Psychiatry 2009;80:423–425.58
95Findley LJ. Epidemiology and genetics of essential tremor. Neurology 2000;54:S8–S13.58
96Halliday DM, Conway BA, Farmer SF, Shahani U, Russell AJC, Rosenberg JR. Coherence between low-frequency activation of the motor cortex and tremor in patients with essential tremor. Lancet 2000;355:1149–1153.58
97Shill HA, Adler CH, Sabbagh MN, et al. Pathologic findings in prospectively ascertained essential tremor subjects. Neurology 2008;70:1452–1455.57
98Rajput AH, Rozdilsky B, Ang L, Rajput A. Significance of Parkinsonian manifestations in essential tremor. Can J Neurol Sci 1993;20:114–117.57
99Goldman MS, Ahlskog JE, Kelly PJ. The symptomatic and functional outcome of stereotactic thalamotomy for medically intractable essential tremor. J Neurosurg 1992;76:924–928.57
100Stefansson H, Steinberg S, Petursson H, et al. Variant in the sequence of the LINGO1 gene confers risk of essential tremor. Nat Genet 2009;41:277–279.56

Basic information concerning country of origin (based on the first author), institution, year of publication, publication name, and citations of the target articles were collected from Web of Science using the analyze tool. Additional analyses were then performed to determine authorship, article type, study design, and level of evidence. For each study, the level of evidence was graded according to Hadorn et al.19

Cited half-life is defined as the number of publication years from the current year, which account for 50% of current citations received.4 This index helps to evaluate the age of the majority of cited articles published in a journal.4 The h-index aims to measure the cumulative impact of a researcher’s output; the value of h is equal to the number of papers (n) that have n or more citations.20

Results

Journals and publication dates of the top-cited articles on ET

The 100 top-cited articles (Table 1) were published in 26 journals. Journal title, impact factor, number of articles, and cited half-life are listed in Table 2. Almost half of the articles were retrieved from two journals: Neurology (n = 31) and Movement Disorders (n = 18). The 100 top-cited articles on ET were published from 1960 to 2010 (Figure 1). The greatest number of top-cited articles (n = 10) were published in 2000, and eight of the top 10-cited articles were published in the 1990s (Table 1) (Figure 1).18,2129 Ninety-one of the articles were published within the past 25 years (Figure 1).

tre-03-186-4307-1-g001.jpg
FIGURE 1

Publication Years for the 100 Top-Cited ET Articles.

TABLE 2

Journals that Published the 100 Top-Cited ET Articles

Impact Factor
RankJournal20115-Year Impact FactorNumber of ArticlesCited Half-Life
1Neurology8.3127.634318.7
2Movement Disorders4.5054.449185.3
3Annals of Neurology11.08910.64479.0
4Brain9.45710.54577.8
5Archives of Neurology7.5846.92878.9
6Journal of Neurology Neurosurgery and Psychiatry4.7644.9536>10.0
7Lancet38.27833.79738.9
8Nature Genetics35.53233.09626.8
9Acta Neurochirurgica1.5201.83929.8
10New England Journal of Medicine53.29850.07517.8
11Lancet Neurology23.46220.59813.8
12Journal of Clinical Investigation13.06915.43019.4
13Proceedings of the National Academy of Sciences of the United States of America9.68110.47217.8
14Nature Clinical Practice Neurology7.6366.71214.4
15Acta Psychiatrica Scandinavica4.2204.2991>10.0
16Parkinsonism & Related Disorders3.7953.17313.9
17European Journal of Neurology3.6923.23914.5
18Journal of Neurology3.4733.20316.5
19Journal of Neurosurgery2.9653.0881>10.0
20Journal of Neural Transmission2.7302.66216.1
21Acta Neurologica Scandinavica2.4692.34719.8
22Journal Neurological Sciences2.3532.44118.7
23Neuroepidemiology2.3052.81716.3
24Neuroscience Letters2.1052.16818.3
25Stereotactic and Functional Neurosurgery1.8491.91319.4
26Canadian Journal of Neurological Sciences0.9681.1771112

Sixty-two authors contributed two or more articles to the list, and five contributed 10 or more (Table 3). The number of authors per article ranged from one to 30, with the most common figures being five (16 articles), three (15 articles), two (12 articles), and seven (12 articles). The most frequent first authors of the top-cited articles in ET were Elan D. Louis (n = 27) and William C. Koller (n = 15); when combined, they accounted for 42% of the articles on the list (Table 3).

TABLE 3

Authors with Two or More Top-Cited ET Articles

RankAuthorNumber of Citation ClassicsNumber of Articlesh-index
As First AuthorAs Co-Author
1Louis ED27171048
2Koller WC1541158
3Jankovic J1221083
4Pahwa R113846
5Lyons K1101121
6Findley LJ93636
7Rajput AH85440
8Rajput A82637
9Benito-León J76129
10Elble R62419
11Deuschl G62456
12Bermejo-Pareja F61520
13Busenbark K51416
14Ford B50535
15Vonsattel JP50534
16Ondo W43120
17Tröster AI41337
18Honig LS40428
19Wilkinson S40417
20Wenzelburger R40416
21Thompson PD40454
22Ottman R40441
23Hubble JP40427
24Brooks DJ40487
25Bain PG32125
26Raethjen J31217
27Speelman JD30332
28Ross GW30339
29Pullman S30312
30Marsden CD303126
31Jurewicz EC30310
32Hariz MI22031
33Connor GS2113
34Colebatch JG21138
35Benabid AL21160
36Stolze H21119
37Deng H21122
38Wills AJ21115
39Alesch F21118
40Hauser W20223
41Weiner WJ20245
42Tang MX20250
43Stefansson K20224
44Schwartz K20219
45Rozdilsky B20229
46Robinson CA2028
47Overman J20210
48Oertel WH20255
49Nash J20214
50Moskowitz CB20214
51Lee H20231
52Kong A2026
53Jenkins IH20216
54Jakobsson F2026
55Higgins JJ20218
56Benedickz J2021
57Frackowiak RSJ20276
58Faust PL20212
59Cote L20233
60Borden S2024
61Barnes LF2027
62Andrews H20226

According to their countries of origin (based on the first author), more than half of the articles were generated in the United States (n = 54), which led the list (Table 4). The United Kingdom (n = 11) was the second-most productive country, followed by Spain (n = 8), Germany (n = 7), and Canada (n = 4). France and Sweden each contributed three articles to the list. The 13 leading institutions that provided two or more top-cited ET articles are listed in Table 5. Columbia University in the United States produced the largest number of top-cited ET articles (n = 19), followed by the University of Kansas (n = 18), and Baylor College of Medicine (n = 9), both in the United States, and Móstoles University Hospital in Spain (n = 6).

TABLE 4

Country of Origin of the 100 Top-Cited ET Articles

RankCountry of OriginNumber of Articles
1USA54
2United Kingdom11
3Spain8
4Germany7
5Canada4
6France3
7Sweden3
8Austria2
9Italy2
10Iceland2
11Finland1
12Belgium1
13Turkey1
14Papua New Guinea1

TABLE 5

Institution of Origin of Authors with Two or More Top-Cited ET Articles

RankCountry of OriginNumber of Articles
1Columbia University, New York, New York, USA19
2University of Kansas Medical Center, Kansas City, Kansas, USA18
3Baylor College of Medicine, Houston, Texas, USA9
4Móstoles University Hospital, Móstoles, Madrid, Spain6
5University of Saskatchewan, Saskatoon, Saskatchewan, Canada5
6Hammersmith Hospital, London, United Kingdom4
7Christian-Albrechts-University of Kiel, Kiel, Germany4
8Oldchurch Hospital, Romford, United Kingdom3
9Institute of Neurology, London, United Kingdom2
10deCODE Genetics, Reykjavik, Iceland2
11Southern Illinois University School of Medicine, Springfield, Illinois, USA2
12University of Vienna, Austria2
13National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland, USA2

Among the 100 top-cited ET articles, a large number had a case-series design (n = 34), and the next most common design was the case-control study (n = 24) (Table 6). Only six articles were clinical trials (Table 6). According to the study designs, the level of evidence of articles is presented in Table 7. Most articles were classified as level B evidence.

TABLE 6

Study Design of the Clinical Studies

Study DesignNumber of Articles
Experimental study
Randomized, controlled trial, open-label trial6
Observational study
Cohort study4
Case-control study24
Descriptive study
Cross-sectional study10
Case series34
Case report2
Methods paper1
Review articles or expert opinion18
Animal research1

TABLE 7

Level of Evidence of the Clinical Studies

Levels of EvidenceNumber of Articles
Level A: Well-conducted RCT with 100 patients or more (including multi-center and meta-analyses); well-conducted RCT with fewer than 100 patients (one or more institutions and meta-analysis; well-conducted study)1
Level B: Well-conducted case-control study, poorly controlled or uncontrolled (including RCT with one or more major or three or more minor methodological flaws), observations studies with high potential for bias (case series with comparison to historical controls), case series or case reports, conflicting evidence with more support79
Level C: Expert opinion18

We also performed an analysis in which we excluded any examples of self-citations (i.e., instances in which authors cited their own work), and the results of this analysis did not change the main findings of the study (e.g., country of origin, institution of origin, top cited authors, etc.).

Discussion

In medical literature, the study of the number of times authors reference an article is one measure of the influence of the publication, and this type of citation analysis is widespread.13 The evaluation of specialty-wide citation analysis has been reported in other areas of the neurosciences.511 By ranking the 100 most-cited works, we aimed to determine which published journal articles on ET have exerted the most citation influence. The top article was cited 293 times. This figure is far lower than that found in Parkinson’s disease, in which the top-cited article garnered 4,327 citations.7

In 2002, Callaham et al.30 found that the impact factor of the original publishing journal, rather than the methodology or quality of the research, was an effective predictor of the number of times an article would be cited per year. However, as shown in the present study (Table 2), the actual citation value of the individual article did not positively relate to the impact factor of the journal.

In general, as shown in Table 3, the 100 top-cited articles in ET were articles that have been available for 10 or more years, and only one target article was published more recently (in 2010). It has been reported that scientific articles begin to be cited 1 or 2 years after publication, and reach a maximum citation rate 7 to 10 years after publication.31 However, an interval of 10 to 20 years is needed for maximal recognition of prominent articles in a field.32,33 This may explain why recently published articles were cited rarely, and few appeared on the list.

Among the 100 top-cited articles on ET, the most common design was the case series design (n = 34), followed by the case-control study (n = 24) (Table 6), implying that descriptive and observational studies are most frequent for ET. This suggests the relative ease of carrying out simpler study designs in ET. It is known that different study designs could correspond to different levels of evidence. In the hierarchy of research study designs, systematic reviews, meta-analyses, and well-conducted randomized clinical trials (RCTs) provide the highest quality of evidence for most clinical or interventional questions, and the lowest grade is applied to expert opinions. Among the 100 target articles, there were only six RCTs. Moreover, only one RCT was found among the top 20 medical articles. This is a common finding among the different studies that have analyzed the 100 most-cited papers in different disciplines.7,31,3436 There are several possible explanations for the low numbers of RCTs. First, RCTs are expensive and time consuming. Second, it is difficult to gather large sample and control groups. Third, it may be that RCTs were published relatively recently, so they had not yet reached a significant number of citations.

Compared to Parkinson’s disease, there are very few articles addressing more basic science issues in ET (e.g., laboratory studies including gene discovery, molecular biology, and cellular biology; neuroimaging studies; neuropathological studies; and animal model studies).7 Scientific understanding of ET is in its infancy.

This study had a number of potential limitations. First and foremost, this survey was restricted to journal articles with the term “essential tremor” in the title. In other words, some significant ET articles could have been excluded, and it is possible that these were high-quality articles with a large number of citations. Second, this type of citation analysis does not include citations in textbooks and lectures, and an author’s or authors’ potential preference to cite articles in the journal in which they seek to publish their work.37 Third, there is a clear time effect in citation analysis, with the most recent articles being at a disadvantage.30 The time from publication played an apparent role here, with late 1990s and early 2000s being the most prominent years of publication for the 100 most-cited articles. Recent articles are clearly disadvantaged in citation analysis. Fourth, the language of publication plays a major role, with an obvious bias for articles published in English-language journals. Fifth, there are biases inherent in the age of the database, as any articles published in the 19th or early 20th century would be excluded, which likely causes some true “classic” articles to be excluded. Finally, Kuhnian philosophy38 would tell us that in a scientific community there is a tendency for adherence to a paradigm. In this context, there is “snowball effect” for citations, as other authors are more likely to cite an article because of previous citations to that article rather than its content or quality.

Notes

[1] Supported by Funding: Dr. Benito-León is supported by the National Institutes of Health, Bethesda, MD, USA (R01 NS039422), and the Commission of the European Union (grant ICT-2011-287739, NeuroTREMOR, principal investigator). Dr. Elan D. Louis has received research support from the National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA (NINDS R01 NS042859, principal investigator; NINDS R01 NS39422, principal investigator; NINDS T32 NS07153-24, principal investigator; NINDS R01 NS073872, principal investigator; NINDS R21 NS077094, co-investigator; and NINDS R01 NS36630, co-investigator) and the Parkinson’s Disease Foundation (principal investigator).

[2] Conflicts of interest Financial disclosures: None.

[3] Conflicts of interest Conflict of Interests: The authors report no conflict of interest.

DOI: https://doi.org/10.5334/tohm.128 | Journal eISSN: 2160-8288
Language: English
Submitted on: Jun 8, 2013
Accepted on: Aug 2, 2013
Published on: Sep 23, 2013
Published by: Columbia University Libraries/Information Services
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year

© 2013 Julián Benito-León, Elan D. Louis, published by Columbia University Libraries/Information Services
This work is licensed under the Creative Commons License.